Baby Wish Comes True with the Help of IVF - The Future of IVF Growth Rates

Abstract

This equity research covers a valuation of the Swedish-based company Vitrolife which operates in the In-Vitro Fertilization (IVF) market. It covers the primary short- and long-term drivers of IVF growth rates which will influence Vitrolife’s financial profile and investment recommendation. Especially, economic slowdown factors will hit demand during the next few years. Additionally, no new technological innovations are to be expected. However, increased maternal age and environmental factors will drive infertility and hence IVF’s long-term growth. With a detailed financial analysis, Vitrolife‘s target price is valued at SEK233.51, which initiates a buy position at a total expected return of +21.34%.